Nano-hydroxyapatite-evoked immune response synchronized with controllable immune adjuvant release for strengthening melanoma-specific growth inhibition

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.

Kensuke Inaba, Muneo Inaba, Nikolaus Romani et al. · The Journal of Experimental Medicine · 1992 · 3.7K citations · Full text

GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c+MHCII+ Macrophages and Dendritic Cells

Julie Helft, Jan P. Böttcher, Probir Chakravarty et al. · Immunity · 2015 · 779 citations · Full text

Inflammation, Bone Marrow Failure, Granulocyte +11

Factors affecting the degradation and drug‐release mechanism of poly(lactic acid) and poly[(lactic acid)‐<i>co</i>‐(glycolic acid)]

Frank Alexis · Polymer International · 2004 · 435 citations

Drug‐release Rate, Engineering, Responsive Polymers +18

First oncolytic virus approved for melanoma immunotherapy

Jonathan Pol, Guido Kroemer, Lorenzo Galluzzi · OncoImmunology · 2015 · 357 citations · Full text

Injectable biodegradable temperature-responsive PLGA–PEG–PLGA copolymers: Synthesis and effect of copolymer composition on the drug release from the copolymer-based hydrogels

Mingxi Qiao, Dawei Chen, MA Xi-chen et al. · International Journal of Pharmaceutics · 2005 · 273 citations

Hydrogels, Engineering, Smart Polymer +9